Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Verisante Technology Inc. V.VRS


Primary Symbol: V.VER.H

Healthcare
Verisante Technology Inc is a Canada based medical device company. It is engaged in commercializing medical systems for the early detection of cancer. The products of the company are Verisante Aura which is for skin cancer detection and Verisante Core which is for lung, colon and cervical cancer detection. It utilizes a cancer detection platform while the operating software and probe technology. The group generates revenue from the sale and renting of its medical devices.


TSXV:VER.H - Post by User

Verisante Technology Inc.
Bullboard Posts
User Avatar Image
(0)
•••
Post by firesIayer96on Aug 10, 2013 1:01pm
487 Views
Post# 21661441

Colon Clinical study

Colon Clinical studyA few links of note related to the Colon Cancer Clinical Study.

https://www.medicine.ubc.ca/files/GASY%20PDF%
20vacancy.pdf

https://www.ncbi.nlm.nih.gov/pubmed/?term=23482035

Looks like the study has a 1-year timeframe allotted.

I would expect many more updates on Core - Lung between now and the completion of the colon clinical study. Its nice to see so many pots on the stove.

The PMI acquisitions from 2011 are also showing their strategic worth.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities